Paper7979274
Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection.
Chen M and 5 others. Antimicrob Agents Chemother, 1994. Cited by 175 papers, by iCite.
Cite this record
ConductScience Library. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Papers, record 7979274. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7979274
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimalarials | Major topic |
| Chalcone | Major topic |
| Malaria | Major topic |
| Plasmodium falciparum | Major topic |
| Plasmodium yoelii | Major topic |
| Animals | |
| Chalcones | |
| Chloroquine | |
| Drug Resistance | |
| Female | |
| Hypoxanthines | |
| Mice | |
| Mice, Inbred BALB C |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3887571 | Qinghaosu (artemisinin): an antimalarial drug from China. | Science | 1985 | https://conductscience.org/library/papers/3887571 | PubMed |
| 2 | 3530122 | Plants as sources of antimalarial drugs: in vitro antimalarial activities of some quassinoids. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3530122 | PubMed |
| 3 | 17226224 | Antiprotozoal agents from plant sources. | Planta Med | 1991 | https://conductscience.org/library/papers/17226224 | PubMed |
| 4 | 2264669 | Plasmodium: resistance to antimalarial drugs. | Ann Parasitol Hum Comp | 1990 | https://conductscience.org/library/papers/2264669 | PubMed |
| 5 | 781840 | Human malaria parasites in continuous culture. | Science | 1976 | https://conductscience.org/library/papers/781840 | PubMed |
| 6 | 2648881 | Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture. | Am J Trop Med Hyg | 1989 | https://conductscience.org/library/papers/2648881 | PubMed |
| 7 | 2605703 | Identification of antimicrobial and antioxidant constituents from licorice of Russian and Xinjiang origin. | Chem Pharm Bull (Tokyo) | 1989 | https://conductscience.org/library/papers/2605703 | PubMed |
| 8 | 2632045 | Phenolic constituents of licorice. II. Structures of licopyranocoumarin, licoarylcoumarin and glisoflavone, and inhibitory effects of licorice phenolics on xanthine oxidase. | Chem Pharm Bull (Tokyo) | 1989 | https://conductscience.org/library/papers/2632045 | PubMed |
| 9 | 15462966 | Spread of chloroquine resistance in Plasmodium falciparum. | Parasitol Today | 1987 | https://conductscience.org/library/papers/15462966 | PubMed |
| 10 | 2572903 | Plasmodium vivax resistance to chloroquine? | Lancet | 1989 | https://conductscience.org/library/papers/2572903 | PubMed |
| 11 | 2183998 | Treatment of malaria--1990. | Drugs | 1990 | https://conductscience.org/library/papers/2183998 | PubMed |
| 12 | 6100431 | Bruceantin, a potent amoebicide from a plant, Brucea antidysenterica. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6100431 | PubMed |
| 13 | 2068748 | Medicinal plants in tropical medicine. 1. Medicinal plants against protozoal diseases. | Trans R Soc Trop Med Hyg | 1991 | https://conductscience.org/library/papers/2068748 | PubMed |
| 14 | 383936 | Synchronization of Plasmodium falciparum erythrocytic stages in culture. | J Parasitol | 1979 | https://conductscience.org/library/papers/383936 | PubMed |
| 15 | 8092835 | Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8092835 | PubMed |
| 16 | 6759151 | Plasmodium falciparum: rapid assay for in vitro inhibition due to human serum from residents of malarious areas. | Exp Parasitol | 1982 | https://conductscience.org/library/papers/6759151 | PubMed |
| 17 | 1896519 | Inhibitory effects of licochalcone A isolated from Glycyrrhiza inflata root on inflammatory ear edema and tumour promotion in mice. | Planta Med | 1991 | https://conductscience.org/library/papers/1896519 | PubMed |
| 18 | 8109916 | Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8109916 | PubMed |
| 19 | 2099092 | [HPLC analysis of flavonoids in the root of six Glycyrrhiza species]. | Yao Xue Xue Bao | 1990 | https://conductscience.org/library/papers/2099092 | PubMed |
| 20 | 1484892 | Effects of three compounds extracted from Morinda lucida on Plasmodium falciparum. | Planta Med | 1992 | https://conductscience.org/library/papers/1484892 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 175 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41484625 | Natural triterpenic phenolic esters target PfA-M17 in Plasmodium falciparum. | Malar J | 2026 | https://conductscience.org/library/papers/41484625 | PubMed |
| 40599794 | Pharmacological potential of natural chalcones: a recent studies and future perspective. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40599794 | PubMed |
| 40526092 | Reverse prenylation in plants by non-canonical aromatic prenyltransferases. | Plant J | 2025 | https://conductscience.org/library/papers/40526092 | PubMed |
| 39650850 | Identification of Coumarin-Chalcone and Coumarin-Pyrazoline Derivatives as Novel Anti-Toxoplasma gondii Agents. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/39650850 | PubMed |
| 39458571 | Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39458571 | PubMed |
| 39273572 | Medicinally Privileged Natural Chalcones: Abundance, Mechanisms of Action, and Clinical Trials. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39273572 | PubMed |
| 38937401 | Significance of Chalcone Scaffolds in Medicinal Chemistry. | Top Curr Chem (Cham) | 2024 | https://conductscience.org/library/papers/38937401 | PubMed |
| 37711130 | Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next? | Curr Med Chem | 2024 | https://conductscience.org/library/papers/37711130 | PubMed |
| 36510199 | Antimalarial and immunomodulatory potential of chalcone derivatives in experimental model of malaria. | BMC Complement Med Ther | 2022 | https://conductscience.org/library/papers/36510199 | PubMed |
| 35744875 | Synthesis and Characterization of Novel Heterocyclic Chalcones from 1-Phenyl-1H-pyrazol-3-ol. | Molecules | 2022 | https://conductscience.org/library/papers/35744875 | PubMed |
| 35335918 | Sparsomycin Exhibits Potent Antiplasmodial Activity In Vitro and In Vivo. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35335918 | PubMed |
| 34808067 | Development of a novel anti-liver fibrosis formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysis. | Pharm Biol | 2021 | https://conductscience.org/library/papers/34808067 | PubMed |
| 34439870 | Chalcones: Synthetic Chemistry Follows Where Nature Leads. | Biomolecules | 2021 | https://conductscience.org/library/papers/34439870 | PubMed |
| 34189299 | Phytochemistry, pharmacological activity, and potential health benefits of Gly cyrrhiza glabra. | Heliyon | 2021 | https://conductscience.org/library/papers/34189299 | PubMed |
| 34187608 | Moringa oleifera extract promotes apoptosis-like death in Toxoplasma gondii tachyzoites in vitro. | Parasitology | 2021 | https://conductscience.org/library/papers/34187608 | PubMed |
| 34122058 | Anti-SARS-CoV-2 Natural Products as Potentially Therapeutic Agents. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34122058 | PubMed |
| 32347726 | Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs. | J Nat Prod | 2020 | https://conductscience.org/library/papers/32347726 | PubMed |
| 31910738 | Ex vivo efficacy of selective chalcone derivatives on reference strains and field isolates of Plasmodium falciparum. | Pathog Glob Health | 2019 | https://conductscience.org/library/papers/31910738 | PubMed |
| 31842914 | In vitro anti-malarial efficacy of chalcones: cytotoxicity profile, mechanism of action and their effect on erythrocytes. | Malar J | 2019 | https://conductscience.org/library/papers/31842914 | PubMed |
| 30123807 | Antiplasmodial Property of Glycyrrhiza glabra Traditionally Used for Malaria in Iran: Promising Activity with High Selectivity Index for Malaria. | J Arthropod Borne Dis | 2018 | https://conductscience.org/library/papers/30123807 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7979274
GET https://conductscience.org/api/papers/v1/7979274/references?page=2